Goater JJ et al. |
Efficacy of ex vivo OPG gene therapy in preventing wear debris induced osteolysis. |
2002 |
J. Orthop. Res. |
pmid:11918293
|
Roux S et al. |
RANK (receptor activator of nuclear factor-kappaB) and RANKL expression in multiple myeloma. |
2002 |
Br. J. Haematol. |
pmid:11918537
|
Oshiro T et al. |
Osteoclast induction in periodontal tissue during experimental movement of incisors in osteoprotegerin-deficient mice. |
2002 |
Anat. Rec. |
pmid:11920384
|
Redlich K et al. |
Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin. |
2002 |
Arthritis Rheum. |
pmid:11920416
|
Khosla S et al. |
Effect of estrogen versus testosterone on circulating osteoprotegerin and other cytokine levels in normal elderly men. |
2002 |
J. Clin. Endocrinol. Metab. |
pmid:11932280
|
Kanematsu M et al. |
Vector-averaged gravity regulates gene expression of receptor activator of NF-kappaB (RANK) ligand and osteoprotegerin in bone marrow stromal cells via cyclic AMP/protein kinase A pathway. |
2002 |
Bone |
pmid:11934645
|
Li X et al. |
Effects of prostaglandin E2 on gene expression in primary osteoblastic cells from prostaglandin receptor knockout mice. |
2002 |
Bone |
pmid:11934647
|
Jain RG and Lenhard JM |
Select HIV protease inhibitors alter bone and fat metabolism ex vivo. |
2002 |
J. Biol. Chem. |
pmid:11937496
|
Schoppet M et al. |
RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function. |
2002 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:11950689
|
Ariyasu T et al. |
Trehalose augments osteoprotegerin production in the FHs74Int human intestinal epithelial cell line. |
2002 |
In Vitro Cell. Dev. Biol. Anim. |
pmid:11963965
|